Salarius Pharmaceuticals

-$0.005 (-0.58%) As of 7:11 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.

About SLRX

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need.

CEO
David J. Arthur
Employees
9
Headquarters
Houston, Texas
Founded
2014

SLRX Key Statistics

Market Cap
49.03M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
594.23K
High Today
$0.8852
Low Today
$0.851
Open Price
$0.883
Volume
373.23K
52 Week High
$3.50
52 Week Low
$0.632

SLRX Earnings

-$0.44
-$0.29
-$0.15
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure